Jingfeng Medical - B (02675.HK) plans to repurchase company shares.

The Zhongtong Finance APP reported that Jingfeng Medical-B (02675.HK) has announced that it plans to exercise the power under the general authorization granted by the resolution passed by the company's shareholders at the company's shareholders' meeting held on June 16, 2025, to repurchase the company's H shares. The Board of Directors has decided to use the share repurchase authorization to repurchase H shares in the public market, with a maximum total amount of 200 million Hong Kong dollars. According to the share repurchase authorization, the number of H shares to be repurchased shall not exceed 10% of the total issued H shares of the Company on the day of listing on the Stock Exchange of Hong Kong (excluding any treasury shares).